S&P 및 Nasdaq 내재가치 문의하기

Miromatrix Medical Inc. MIRO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
54/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.00
+165.5%

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Miromatrix Medical Inc. (MIRO), 포함 29 건 매수18 건 매도. 내부자 매수 총액은 $999.39K 내부자 매도 총액은 $2.08M.

최근 활동이 있는 주요 내부자에는 Kattungal Laji, Erb John L, Buckman Paul. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — MIRO

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2024-07-16 Kattungal Laji Vice President of Quality 처분 80,000 $3.75 $300K -
2023-12-13 Erb John L Director 주식 반환 25,000 $3.75 $93.75K -
2023-12-13 Buckman Paul Director 주식 반환 25,000 $3.75 $93.75K -
2023-12-13 Maag Peter Director 주식 반환 58,368 - - -
2023-12-13 Burke William P. Mr. Director 주식 반환 67,413 - - -
2023-12-13 Heine Lisa Wipperman Director 주식 반환 67,413 - - -
2023-12-13 Ross Jeffrey James Chief Executive Officer 주식 반환 100,000 $3.26 $326K -
2023-12-13 Douglas James Michael Chief Financial Officer 주식 반환 40,000 $3.26 $130.4K -
2023-12-12 Erb John L Director 공개매수 (매도) 56,260 $1.75 $98.46K 54,201
2023-12-12 Buckman Paul Director 공개매수 (매도) 52,593 $1.75 $92.04K 54,201
2023-12-12 Maag Peter Director 공개매수 (매도) 62,092 $1.75 $108.66K 58,368
2023-12-12 Burke William P. Mr. Director 공개매수 (매도) 66,943 $1.75 $117.15K 67,413
2023-12-12 Heine Lisa Wipperman Director 공개매수 (매도) 66,943 $1.75 $117.15K 67,413
2023-12-12 Ross Jeffrey James Chief Executive Officer 공개매수 (매도) 308,775 $1.75 $540.36K 87,500
2023-12-12 Douglas James Michael Chief Financial Officer 공개매수 (매도) 31,250 $1.75 $54.69K 20,000
2023-12-12 United Therapeutics Corp 10 Percent Owner 처분 - - - 27,419,228
2023-06-01 Erb John L Director RSU 부여 54,201 - - 110,461
2023-06-01 Buckman Paul Director RSU 부여 54,201 - - 106,794
2023-06-01 Maag Peter Director RSU 부여 54,201 - - 120,460
2023-06-01 Burke William P. Mr. Director RSU 부여 54,201 - - 134,356
2023-06-01 Heine Lisa Wipperman Director RSU 부여 54,201 - - 134,356
2023-03-10 Erb John L Director 정보 매수 31,250 $1.60 $50K 56,260
2023-03-10 Buckman Paul Director 정보 매수 31,250 $1.60 $50K 52,593
2023-03-10 Maag Peter Director 정보 매수 31,250 $1.60 $50K 66,259
2023-03-10 Burke William P. Mr. Director 정보 매수 31,250 $1.60 $50K 80,155
2023-03-10 Heine Lisa Wipperman Director 정보 매수 31,250 $1.60 $50K 80,155
2023-03-10 Ross Jeffrey James Chief Executive Officer 정보 매수 31,250 $1.60 $50K 396,276
2023-03-10 Barry John Joseph Vice President of R&d 정보 매수 6,250 $1.60 $10K 35,485
2023-03-10 Douglas James Michael Chief Financial Officer 정보 매수 31,250 $1.60 $50K 51,250
2023-01-13 Ross Jeffrey James Chief Executive Officer RSU 부여 100,000 - - 100,000
2023-01-13 Barry John Joseph Vice President of R&d RSU 부여 20,000 - - 20,000
2023-01-13 Douglas James Michael Chief Financial Officer RSU 부여 20,000 - - 20,000
2022-12-06 Ross Jeffrey James Chief Executive Officer 옵션 행사 (매도) 37,500 - - -
2022-10-01 Barry John Joseph Vice President of R&d RSU 원천징수 765 $4.38 $3.35K 19,235
2022-08-10 Erb John L Director RSU 부여 12,788 - - 25,010
2022-08-10 Buckman Paul Director RSU 부여 12,788 - - 21,343
2022-08-10 Maag Peter Director RSU 부여 12,788 - - 35,009
2022-08-10 Burke William P. Mr. Director RSU 부여 12,788 - - 48,905
2022-08-10 Heine Lisa Wipperman Director RSU 부여 12,788 - - 48,905
2022-03-15 Ross Jeffrey James Chief Executive Officer 옵션 행사 35,438 $1.25 $44.3K 293,588
2022-03-01 Douglas James Michael Officer 알 수 없음 - - - -
2022-03-01 Douglas James Michael Chief Financial Officer RSU 부여 180,000 - - 180,000
2022-01-13 Niebur Brian Chief Financial Officer RSU 부여 20,000 $4.20 $84K 20,000
2022-01-13 Kattungal Laji Vice President of Quality RSU 부여 10,000 - - 10,000
2022-01-13 Ross Jeffrey James Chief Executive Officer RSU 부여 100,000 $4.20 $420K 100,000
2022-01-13 Barry John Joseph Vice President of R&d RSU 부여 20,000 $4.20 $84K 20,000
2022-01-03 Niebur Brian Chief Financial Officer RSU 부여 1,500 $4.73 $7.1K 1,500
2022-01-03 Burke William P. Mr. Director 알 수 없음 - - - -
2022-01-03 Burke William P. Mr. Director RSU 부여 4,405 - - 4,405
2022-01-03 Heine Lisa Wipperman Director 알 수 없음 - - - -
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기